| 10538 | -1.604 | 5.112 | -28.54 | 4.421e-87 | 5.625e-86 | 187.8 | 10538 | BATF | basic leucine zipper transcription factor, ATF-like | ENSG00000156127 | 612476 |
| 10578 | -0.7156 | 4.055 | -20.37 | 2.677e-58 | 1.718e-57 | 121.5 | 10578 | GNLY | granulysin | ENSG00000115523 | 188855 |
| 10603 | -2.132 | 6.628 | -22.95 | 1.028e-67 | 8.305e-67 | 143.2 | 10603 | SH2B2 | SH2B adaptor protein 2 | NA | 605300 |
| 10859 | -1.754 | 4.411 | -25.98 | 2.079e-78 | 2.154e-77 | 167.8 | 10859 | LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | ENSG00000104972 | 604811 |
| 11025 | -2.354 | 5.439 | -35.21 | 5.451e-108 | 1.228e-106 | 236 | 11025 | LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | ENSG00000204577 | 604820 |
| 1234 | -1.948 | 4.807 | -40.35 | 1.696e-122 | 5.983e-121 | 269.5 | 1234 | CCR5 | chemokine (C-C motif) receptor 5 (gene/pseudogene) | ENSG00000160791 | 601373, 609532, 610379, 612522 |
| 1269 | -3.239 | 4.775 | -57.57 | 4.605e-163 | 1.036e-160 | 362.9 | 1269 | CNR2 | cannabinoid receptor 2 (macrophage) | ENSG00000188822 | 605051 |
| 1378 | -0.6643 | 4.072 | -19.18 | 7.117e-54 | 4.159e-53 | 111.3 | 1378 | CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | ENSG00000203710 | 120620, 607486, 611162 |
| 1435 | -1.452 | 4.31 | -35 | 2.298e-107 | 5.084e-106 | 234.6 | 1435 | CSF1 | colony stimulating factor 1 (macrophage) | ENSG00000184371 | 120420 |
| 150 | -0.7381 | 3.897 | -22.57 | 2.391e-66 | 1.875e-65 | 140.1 | 150 | ADRA2A | adrenergic, alpha-2A-, receptor | ENSG00000150594 | 104210 |
| 1511 | -1.523 | 4.533 | -33.29 | 3.415e-102 | 6.382e-101 | 222.7 | 1511 | CTSG | cathepsin G | ENSG00000100448 | 116830 |
| 1669 | -0.955 | 4.085 | -22.36 | 1.317e-65 | 1.014e-64 | 138.3 | 1669 | DEFA4 | defensin, alpha 4, corticostatin | ENSG00000164821 | 601157 |
| 181 | -0.9688 | 4.279 | -23.34 | 4.082e-69 | 3.413e-68 | 146.4 | 181 | AGRP | agouti related protein homolog (mouse) | ENSG00000159723 | 601665, 602311 |
| 1896 | -2.519 | 4.988 | -39.39 | 6.841e-120 | 2.183e-118 | 263.5 | 1896 | EDA | ectodysplasin A | ENSG00000158813 | 300451, 305100, 313500 |
| 1961 | -1.13 | 4.441 | -21.43 | 3.333e-62 | 2.355e-61 | 130.5 | 1961 | EGR4 | early growth response 4 | ENSG00000135625 | 128992 |
| 2012 | 1.264 | 5.394 | 19.32 | 2.023e-54 | 1.197e-53 | 112.6 | 2012 | EMP1 | epithelial membrane protein 1 | ENSG00000134531 | 602333 |
| 214 | 1.354 | 10.92 | 20.46 | 1.167e-58 | 7.566e-58 | 122.3 | 214 | ALCAM | activated leukocyte cell adhesion molecule | ENSG00000170017 | 601662 |
| 2220 | -2.633 | 4.576 | -41.34 | 3.672e-125 | 1.45e-123 | 275.6 | 2220 | FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | ENSG00000160339 | 601624 |
| 2251 | -1.457 | 4.921 | -26.19 | 3.839e-79 | 4.057e-78 | 169.5 | 2251 | FGF6 | fibroblast growth factor 6 | ENSG00000111241 | 134921 |
| 22914 | -1.442 | 4.469 | -26.05 | 1.165e-78 | 1.213e-77 | 168.4 | 22914 | KLRK1 | killer cell lectin-like receptor subfamily K, member 1 | ENSG00000213809 | 611817 |
| 2322 | -0.8707 | 4.055 | -24.58 | 1.505e-73 | 1.391e-72 | 156.6 | 2322 | FLT3 | fms-related tyrosine kinase 3 | ENSG00000122025 | 136351, 601626 |
| 23495 | -2.034 | 5.071 | -30.19 | 1.847e-92 | 2.709e-91 | 200.2 | 23495 | TNFRSF13B | tumor necrosis factor receptor superfamily, member 13B | ENSG00000240505 | 240500, 604907, 609529 |
| 24138 | 1.932 | 7.74 | 27.26 | 8.919e-83 | 1.033e-81 | 177.9 | 24138 | IFIT5 | interferon-induced protein with tetratricopeptide repeats 5 | ENSG00000152778 | NA |
| 2621 | -2.263 | 7.88 | -24.58 | 1.498e-73 | 1.385e-72 | 156.7 | 2621 | GAS6 | growth arrest-specific 6 | ENSG00000183087 | 600441 |
| 3077 | -3.66 | 4.955 | -61.39 | 1.04e-170 | 3.457e-168 | 380.5 | 3077 | HFE | hemochromatosis | ENSG00000010704 | 104300, 176100, 176200, 190000, 235200, 612635, 613609, 614193 |
| 3107 | -1.254 | 10.21 | -19.7 | 7.623e-56 | 4.606e-55 | 115.9 | 3107 | HLA-C | major histocompatibility complex, class I, C | ENSG00000204525, ENSG00000233841, ENSG00000225691, ENSG00000206435, ENSG00000237022, ENSG00000206452, ENSG00000228299 | 142840, 177900, 609423 |
| 3109 | -1.394 | 5.021 | -23.82 | 7.536e-71 | 6.586e-70 | 150.4 | 3109 | HLA-DMB | major histocompatibility complex, class II, DM beta | ENSG00000242092, ENSG00000242574, ENSG00000241674, ENSG00000226264, ENSG00000234154, ENSG00000239329, ENSG00000242386, ENSG00000241296 | 142856 |
| 3111 | -2.489 | 4.807 | -34.77 | 1.139e-106 | 2.471e-105 | 233 | 3111 | HLA-DOA | major histocompatibility complex, class II, DO alpha | ENSG00000232957, ENSG00000204252, ENSG00000206292, ENSG00000235744, ENSG00000232962, ENSG00000231558, ENSG00000230141 | 142930 |
| 3135 | -2.82 | 6.798 | -49.26 | 6.861e-145 | 6.395e-143 | 321 | 3135 | HLA-G | major histocompatibility complex, class I, G | ENSG00000237216, ENSG00000235680, ENSG00000233095, ENSG00000206506, ENSG00000235346, ENSG00000204632, ENSG00000230413 | 142871, 600807 |
| 3479 | -1.131 | 4.493 | -23.11 | 2.629e-68 | 2.164e-67 | 144.6 | 3479 | IGF1 | insulin-like growth factor 1 (somatomedin C) | ENSG00000017427 | 147440, 608747 |
| 348 | -0.7803 | 3.747 | -23.36 | 3.294e-69 | 2.767e-68 | 146.6 | 348 | APOE | apolipoprotein E | ENSG00000130203 | 104310, 107741, 269600, 603075, 611771 |
| 3556 | 1.767 | 6.718 | 20.6 | 3.819e-59 | 2.512e-58 | 123.5 | 3556 | IL1RAP | interleukin 1 receptor accessory protein | ENSG00000196083 | 602626 |
| 3560 | -2.359 | 4.722 | -40.76 | 1.261e-123 | 4.667e-122 | 272.1 | 3560 | IL2RB | interleukin 2 receptor, beta | ENSG00000100385 | 146710 |
| 3561 | -1.754 | 4.685 | -35.05 | 1.664e-107 | 3.71e-106 | 234.9 | 3561 | IL2RG | interleukin 2 receptor, gamma | ENSG00000147168 | 300400, 308380, 312863 |
| 3600 | 2.068 | 6.698 | 22.31 | 2.033e-65 | 1.557e-64 | 137.9 | 3600 | IL15 | interleukin 15 | ENSG00000164136 | 600554 |
| 3601 | -1.233 | 5.345 | -19.54 | 3.005e-55 | 1.797e-54 | 114.5 | 3601 | IL15RA | interleukin 15 receptor, alpha | ENSG00000134470 | 601070 |
| 3627 | -1.269 | 4.314 | -24.58 | 1.52e-73 | 1.403e-72 | 156.6 | 3627 | CXCL10 | chemokine (C-X-C motif) ligand 10 | ENSG00000169245 | 147310 |
| 3638 | 2.278 | 8.655 | 23.08 | 3.268e-68 | 2.676e-67 | 144.4 | 3638 | INSIG1 | insulin induced gene 1 | ENSG00000186480 | 602055 |
| 3811 | -1.262 | 4.327 | -23.23 | 9.471e-69 | 7.861e-68 | 145.6 | 3811 | KIR3DL1 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 | ENSG00000167633 | 604946, 609423 |
| 3929 | -2.077 | 4.781 | -32.48 | 1.006e-99 | 1.764e-98 | 217 | 3929 | LBP | lipopolysaccharide binding protein | ENSG00000129988 | 151990 |
| 4035 | -1.858 | 5.859 | -24.57 | 1.702e-73 | 1.569e-72 | 156.5 | 4035 | LRP1 | low density lipoprotein receptor-related protein 1 | ENSG00000123384 | 107770 |
| 4046 | -1.315 | 4.736 | -22.85 | 2.194e-67 | 1.759e-66 | 142.4 | 4046 | LSP1 | lymphocyte-specific protein 1 | ENSG00000130592 | 153432 |
| 4049 | -1.282 | 4.257 | -30.63 | 6.787e-94 | 1.035e-92 | 203.5 | 4049 | LTA | lymphotoxin alpha (TNF superfamily, member 1) | ENSG00000226979, ENSG00000238130, ENSG00000226275, ENSG00000230279, ENSG00000231408, ENSG00000173503, ENSG00000223919 | 153440, 607507, 608446, 610988 |
| 4057 | -1.467 | 4.185 | -37.58 | 7.959e-115 | 2.197e-113 | 251.8 | 4057 | LTF | lactotransferrin | ENSG00000012223 | 150210 |
| 4261 | -0.9479 | 4.475 | -22.71 | 7.451e-67 | 5.922e-66 | 141.2 | 4261 | CIITA | class II, major histocompatibility complex, transactivator | ENSG00000179583 | 126200, 180300, 209920, 600005 |
| 4283 | -1.117 | 4.529 | -19.95 | 8.947e-57 | 5.512e-56 | 118 | 4283 | CXCL9 | chemokine (C-X-C motif) ligand 9 | ENSG00000138755 | 601704 |
| 4524 | -1.12 | 4.394 | -22.06 | 1.616e-64 | 1.209e-63 | 135.8 | 4524 | MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) | ENSG00000177000 | 119530, 181500, 188050, 236250, 601634, 607093 |
| 4600 | -1.121 | 4.308 | -20.47 | 1.123e-58 | 7.286e-58 | 122.4 | 4600 | MX2 | myxovirus (influenza virus) resistance 2 (mouse) | ENSG00000183486 | 147890 |
| 5133 | -1.477 | 4.366 | -27.04 | 4.822e-82 | 5.472e-81 | 176.2 | 5133 | PDCD1 | programmed cell death 1 | ENSG00000188389 | 126200, 152700, 600244, 605218 |
| 5155 | -3.179 | 5.038 | -44.37 | 5.245e-133 | 2.762e-131 | 293.7 | 5155 | PDGFB | platelet-derived growth factor beta polypeptide | ENSG00000100311 | 190040 |
| 5196 | -1.548 | 5.232 | -21.65 | 4.979e-63 | 3.595e-62 | 132.4 | 5196 | PF4 | platelet factor 4 | ENSG00000163737 | 173460 |
| 5724 | -2.393 | 5.425 | -30.43 | 3.028e-93 | 4.537e-92 | 202 | 5724 | PTAFR | platelet-activating factor receptor | ENSG00000169403 | 173393 |
| 586 | -1.288 | 4.319 | -24.06 | 1.087e-71 | 9.674e-71 | 152.4 | 586 | BCAT1 | branched chain amino-acid transaminase 1, cytosolic | ENSG00000060982 | 113520 |
| 596 | -0.9345 | 4.159 | -21.37 | 5.332e-62 | 3.753e-61 | 130 | 596 | BCL2 | B-cell CLL/lymphoma 2 | ENSG00000171791 | 151430 |
| 604 | -1.892 | 5.054 | -21.01 | 1.132e-60 | 7.705e-60 | 127 | 604 | BCL6 | B-cell CLL/lymphoma 6 | ENSG00000113916 | 109565 |
| 6346 | -0.9223 | 4.043 | -24.63 | 1.034e-73 | 9.598e-73 | 157 | 6346 | CCL1 | chemokine (C-C motif) ligand 1 | ENSG00000108702 | 182281 |
| 6351 | -1.721 | 4.326 | -32.04 | 2.468e-98 | 4.165e-97 | 213.8 | 6351 | CCL4 | chemokine (C-C motif) ligand 4 | ENSG00000129277 | 182284 |
| 6362 | -2.873 | 4.267 | -48.64 | 1.977e-143 | 1.74e-141 | 317.7 | 6362 | CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | ENSG00000006074 | 603757 |
| 6376 | -1.64 | 4.656 | -30.49 | 1.886e-93 | 2.842e-92 | 202.5 | 6376 | CX3CL1 | chemokine (C-X3-C motif) ligand 1 | ENSG00000006210 | 601880 |
| 6387 | -1.919 | 4.366 | -33.16 | 8.406e-102 | 1.559e-100 | 221.8 | 6387 | CXCL12 | chemokine (C-X-C motif) ligand 12 | ENSG00000107562 | 600835, 609423 |
| 6403 | -2.425 | 4.489 | -43.29 | 2.876e-130 | 1.354e-128 | 287.4 | 6403 | SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | ENSG00000174175 | 147050, 173610 |
| 671 | -0.9848 | 3.969 | -27.17 | 1.714e-82 | 1.967e-81 | 177.3 | 671 | BPI | bactericidal/permeability-increasing protein | ENSG00000101425 | 109195 |
| 6776 | -2.889 | 4.809 | -36.33 | 2.99e-111 | 7.377e-110 | 243.5 | 6776 | STAT5A | signal transducer and activator of transcription 5A | ENSG00000126561 | 601511 |
| 684 | -0.837 | 3.971 | -19.25 | 3.675e-54 | 2.162e-53 | 112 | 684 | BST2 | bone marrow stromal cell antigen 2 | ENSG00000130303 | 600534 |
| 7039 | -1.587 | 4.83 | -21.46 | 2.474e-62 | 1.753e-61 | 130.8 | 7039 | TGFA | transforming growth factor, alpha | ENSG00000163235 | 190170 |
| 717 | -1.954 | 4.764 | -34.52 | 6.538e-106 | 1.386e-104 | 231.2 | 717 | C2 | complement component 2 | ENSG00000231543, ENSG00000166278, ENSG00000235017, ENSG00000235696, ENSG00000226560, ENSG00000204364, ENSG00000206372 | 217000, 603075, 613927 |
| 722 | -2.504 | 4.682 | -40.48 | 7.166e-123 | 2.583e-121 | 270.3 | 722 | C4BPA | complement component 4 binding protein, alpha | ENSG00000123838 | 120830 |
| 732 | -1.608 | 4.67 | -28.06 | 1.796e-85 | 2.202e-84 | 184.1 | 732 | C8B | complement component 8, beta polypeptide | ENSG00000021852 | 120960, 613789 |
| 7369 | -0.9757 | 4.159 | -23.11 | 2.686e-68 | 2.208e-67 | 144.5 | 7369 | UMOD | uromodulin | ENSG00000169344 | 162000, 191845, 603860, 609886 |
| 7433 | -3.332 | 4.736 | -56.61 | 4.43e-161 | 9.223e-159 | 358.3 | 7433 | VIPR1 | vasoactive intestinal peptide receptor 1 | ENSG00000114812 | 192321 |
| 7852 | -2.371 | 4.748 | -24.6 | 1.338e-73 | 1.239e-72 | 156.8 | 7852 | CXCR4 | chemokine (C-X-C motif) receptor 4 | ENSG00000121966 | 162643, 193670 |
| 7940 | -2.826 | 4.6 | -53.01 | 2.21e-153 | 2.965e-151 | 340.6 | 7940 | LST1 | leukocyte specific transcript 1 | ENSG00000235915, ENSG00000204482, ENSG00000226182, ENSG00000234514, ENSG00000230791, ENSG00000231048, ENSG00000206433, ENSG00000223465 | 109170 |
| 8190 | -2.015 | 4.764 | -33 | 2.597e-101 | 4.766e-100 | 220.6 | 8190 | MIA | melanoma inhibitory activity | ENSG00000167578 | 601340 |
| 8484 | -4.201 | 4.813 | -62.06 | 5.149e-172 | 1.912e-169 | 383.5 | 8484 | GALR3 | galanin receptor 3 | ENSG00000128310 | 603692 |
| 8519 | -3.497 | 5.957 | -22.12 | 9.513e-65 | 7.157e-64 | 136.4 | 8519 | IFITM1 | interferon induced transmembrane protein 1 (9-27) | ENSG00000185885 | 604456 |
| 8530 | -1.656 | 4.534 | -33.89 | 4.809e-104 | 9.523e-103 | 226.9 | 8530 | CST7 | cystatin F (leukocystatin) | ENSG00000077984 | 603253 |
| 8600 | -2.807 | 4.085 | -52.89 | 4.129e-153 | 5.508e-151 | 340 | 8600 | TNFSF11 | tumor necrosis factor (ligand) superfamily, member 11 | ENSG00000120659 | 259710, 602642 |
| 8742 | -1.379 | 5.402 | -23.23 | 9.732e-69 | 8.072e-68 | 145.6 | 8742 | TNFSF12 | tumor necrosis factor (ligand) superfamily, member 12 | ENSG00000239697 | 602695 |
| 8851 | -0.8205 | 3.836 | -19.68 | 9.785e-56 | 5.901e-55 | 115.6 | 8851 | CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) | ENSG00000176749 | 603460 |
| 8993 | -1.319 | 4.491 | -27.28 | 7.423e-83 | 8.612e-82 | 178.1 | 8993 | PGLYRP1 | peptidoglycan recognition protein 1 | ENSG00000008438 | 604963 |
| 910 | -1.173 | 4.263 | -22.32 | 1.895e-65 | 1.454e-64 | 138 | 910 | CD1B | CD1b molecule | ENSG00000158485 | 188360 |
| 911 | -3.284 | 4.596 | -60.41 | 8.592e-169 | 2.622e-166 | 376 | 911 | CD1C | CD1c molecule | ENSG00000158481 | 188340 |
| 914 | -1.833 | 4.725 | -32.49 | 9.874e-100 | 1.735e-98 | 217 | 914 | CD2 | CD2 molecule | ENSG00000116824 | 186990 |
| 917 | -1.369 | 4.299 | -29.69 | 7.616e-91 | 1.072e-89 | 196.5 | 917 | CD3G | CD3g molecule, gamma (CD3-TCR complex) | ENSG00000160654 | 186740 |
| 919 | -1.96 | 4.604 | -39.45 | 4.553e-120 | 1.47e-118 | 263.9 | 919 | CD247 | CD247 molecule | ENSG00000198821 | 186780, 610163 |
| 920 | -2.454 | 4.57 | -44.08 | 2.75e-132 | 1.396e-130 | 292 | 920 | CD4 | CD4 molecule | ENSG00000010610 | 186940, 613949 |
| 921 | -3.594 | 4.777 | -72.11 | 3.815e-190 | 7.725e-187 | 425.1 | 921 | CD5 | CD5 molecule | ENSG00000110448 | 153340 |
| 923 | -3.566 | 5.285 | -47.37 | 2.108e-140 | 1.55e-138 | 310.7 | 923 | CD6 | CD6 molecule | ENSG00000013725 | 186720 |
| 925 | -1.785 | 4.463 | -29.22 | 2.495e-89 | 3.361e-88 | 193 | 925 | CD8A | CD8a molecule | ENSG00000153563 | 186910, 608957 |
| 926 | -2.586 | 4.462 | -40.36 | 1.534e-122 | 5.423e-121 | 269.6 | 926 | CD8B | CD8b molecule | ENSG00000172116 | 186730 |
| 933 | -2.861 | 5.796 | -29.32 | 1.199e-89 | 1.63e-88 | 193.7 | 933 | CD22 | CD22 molecule | ENSG00000012124 | 107266 |
| 942 | -0.7486 | 3.85 | -26.42 | 6.3e-80 | 6.797e-79 | 171.3 | 942 | CD86 | CD86 molecule | ENSG00000114013 | 601020 |
| 9450 | -2.142 | 4.617 | -33.65 | 2.718e-103 | 5.251e-102 | 225.2 | 9450 | LY86 | lymphocyte antigen 86 | ENSG00000112799 | 605241 |
| 953 | -1.168 | 5.178 | -20.2 | 1.124e-57 | 7.075e-57 | 120.1 | 953 | ENTPD1 | ectonucleoside triphosphate diphosphohydrolase 1 | ENSG00000138185 | 601752 |
| 958 | -3.752 | 5.805 | -45.44 | 1.1e-135 | 6.465e-134 | 299.8 | 958 | CD40 | CD40 molecule, TNF receptor superfamily member 5 | ENSG00000101017 | 109535, 606843 |
| 962 | -2.586 | 4.619 | -42.78 | 6.204e-129 | 2.792e-127 | 284.3 | 962 | CD48 | CD48 molecule | ENSG00000117091 | 109530 |
| 963 | -2.86 | 4.731 | -46 | 4.492e-137 | 2.787e-135 | 303 | 963 | CD53 | CD53 molecule | ENSG00000143119 | 151525 |